Brief Report: Differential Timing of Cholesterol Increase During Successful HCV Therapy: Impact of Type of Drug Combination-Reference-Cited by-同舟云学术

Brief Report: Differential Timing of Cholesterol Increase During Successful HCV Therapy: Impact of Type of Drug Combination

Published:2018-08-01 Issue:4 Volume:78 Page:437-440
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Rivero-Juarez Antonio,Camacho Angela,Brieva Teresa,Frias Mario,Lopez-Lopez Pedro,Risalde María A.,Machuca Isabel,Caston Juan J.,Martínez-Peinado Antonio,Rivero Antonio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference13 articles.

1. Cholesterol and chronic hepatitis C virus infection;Honda;Hepatol Res.,2011

2. Metabolic manifestations of hepatitis C virus: diabetes mellitus, dyslipidemia;Serfaty;Clin Liver Dis.,2017

3. Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients;Meissner;Hepatology,2015

4. Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin;Younossi;J Hepatol.,2016

5. Interfero-free treatment of hepatitis C virus in HIV/hepatitis C virus-coinfected subjects in increase serum low-density lipoprotein concentration;Townsend;AIDS Res Hum Retroviruses,2016

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anthropometric parameters and liver histology influence lipid metabolic changes in HCV chronic hepatitis on direct-acting antiviral treatment;Annals of Translational Medicine;2021-01

2. The clinically licensed antifungal drug itraconazole inhibits influenza virus in vitro and in vivo;Emerging Microbes & Infections;2019-01-01